Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 212,468,257 papers from all fields of science
Search
Sign In
Create Free Account
Cancer Vaccines
Known as:
vaccines cancer
, Tumor Vaccine
, Cancer Vaccines [Chemical/Ingredient]
Expand
Vaccines or candidate vaccines designed to prevent or treat cancer. Vaccines are produced using the patient's own whole tumor cells as the source of…
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
49 relations
Narrower (41)
ALVAC-CEA vaccine
Algenpantucel-L
CDX 1307
CHP-HER2 vaccine
Expand
In Blood
Papillomavirus Vaccines
Process of secretion
agonists
Expand
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Review
2018
Review
2018
Personalized vaccines for cancer immunotherapy
U. Şahin
,
Ö. Türeci
Science
2018
Corpus ID: 4307028
Cancer is characterized by an accumulation of genetic alterations. Somatic mutations can generate cancer-specific neoepitopes…
Expand
Review
2017
Review
2017
Towards personalized, tumour-specific, therapeutic vaccines for cancer
Zhuting Hu
,
P. Ott
,
Catherine J. Wu
Nature reviews. Immunology
2017
Corpus ID: 3515147
Cancer vaccines, which are designed to amplify tumour-specific T cell responses through active immunization, have long been…
Expand
Highly Cited
2016
Highly Cited
2016
Designer vaccine nanodiscs for personalized cancer immunotherapy
Rui Kuai
,
Lukasz J. Ochyl
,
K. Bahjat
,
A. Schwendeman
,
J. Moon
Nature Materials
2016
Corpus ID: 33592854
Despite the tremendous potential of peptide-based cancer vaccines, their efficacy has been limited in humans. Recent innovations…
Expand
Review
2014
Review
2014
Therapeutic vaccines for cancer: an overview of clinical trials
I. Melero
,
G. Gaudernack
,
+8 authors
H. Mellstedt
Nature Reviews Clinical Oncology
2014
Corpus ID: 1069558
The therapeutic potential of host-specific and tumour-specific immune responses is well recognized and, after many years, active…
Expand
Review
2007
Review
2007
DC-based cancer vaccines.
E. Gilboa
Journal of Clinical Investigation
2007
Corpus ID: 36402322
Because of the large preexisting antigenic load and immunosuppressive environment within a tumor, inducing therapeutically useful…
Expand
Highly Cited
2005
Highly Cited
2005
Therapeutic cancer vaccines
F. Pijpers
,
Richard Faint
,
Nishu Saini
Nature reviews. Drug discovery
2005
Corpus ID: 6924708
Unmet needs across the oncology market remain high, with most traditional therapies representing a trade-off between levels of…
Expand
Review
2005
Review
2005
Cancer/testis antigens, gametogenesis and cancer
A. Simpson
,
O. Caballero
,
A. Jungbluth
,
Yao-Tseng Chen
,
L. Old
Nature Reviews. Cancer
2005
Corpus ID: 2000946
Cancer/testis (CT) antigens, of which more than 40 have now been identified, are encoded by genes that are normally expressed…
Expand
Highly Cited
2004
Highly Cited
2004
Cancer immunotherapy: moving beyond current vaccines
S. Rosenberg
,
J. Yang
,
N. Restifo
Nature Network Boston
2004
Corpus ID: 13785133
Great progress has been made in the field of tumor immunology in the past decade, but optimism about the clinical application of…
Expand
Review
2003
Review
2003
Cancer vaccines: between the idea and the reality
O. Finn
Nature reviews. Immunology
2003
Corpus ID: 6861735
Whether vaccines are designed to prepare the immune system for the encounter with a pathogen or with cancer, certain common…
Expand
Highly Cited
1994
Highly Cited
1994
Role of bone marrow-derived cells in presenting MHC class I-restricted tumor antigens.
A. Huang
,
P. Golumbek
,
M. Ahmadzadeh
,
E. Jaffee
,
D. Pardoll
,
H. Levitsky
Science
1994
Corpus ID: 32652315
Many tumors express tumor-specific antigens capable of being presented to CD8+ T cells by major histocompatibility complex (MHC…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE